Center-Authored Papers

Filters: Author is Mujugira, Andrew  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Barnabas RV, Baeten JM, Lingappa JR, Thomas KK, Hughes JP, Mugo NR, Delany-Moretlwe S, Gray G, Rees H, Mujugira A et al..  2015.  Acyclovir Prophylaxis Reduces the Incidence of Herpes Zoster Among HIV-Infected Individuals: Results of a Randomized Clinical Trial.. The Journal of infectious diseases. Abstract
Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, Tappero JW, Bukusi EA, Cohen CR, Katabira E et al..  2012.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.. The New England journal of medicine. 367(5):399-410. Abstract
C
Lingappa JR, Kahle E, Mugo N, Mujugira A, Magaret AS, Baeten J, Bukusi EA, Cohen CR, Katabira E, Ronald A et al..  2009.  Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study.. PloS one. 4(4):e5272. Abstract
Mujugira A, Baeten JM, Donnell D, Ndase P, Mugo NR, Barnes L, Campbell JD, Wangisi J, Tappero JW, Bukusi E et al..  2011.  Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention.. PloS one. 6(10):e25828. Abstract
Donnell DJ, Baeten JM, Hong T, Lingappa JR, Mujugira A, Nakku-Joloba E, Bangsberg D, Celum C.  2013.  Correlation Between Pill Counts and Biologic Effects in an HIV-1 Prevention Clinical Trial: Implications for Measuring Adherence.. AIDS and behavior. 17(2):632-9. Abstract
D
Lingappa JR, Baeten JM, Wald A, Hughes JP, Thomas KK, Mujugira A, Mugo N, Bukusi EA, Cohen CR, Katabira E et al..  2010.  Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.. Lancet. 375(9717):824-33. Abstract
Mujugira A, Magaret AS, Celum C, Baeten JM, Lingappa JR, Morrow RA, Fife KH, Delany-Moretlwe S, de Bruyn G, Bukusi EA et al..  2013.  Daily Acyclovir to Decrease Herpes Simplex Virus Type 2 (HSV-2) Transmission from HSV-2/HIV-1 Coinfected Persons: A Randomized Controlled Trial.. The Journal of infectious diseases. Abstract
Celum C, Morrow RA, Donnell D, Hong T, Hendrix CW, Thomas KK, Fife KH, Nakku-Joloba E, Mujugira A, Baeten JM.  2014.  Daily Oral Tenofovir and Emtricitabine-Tenofovir Preexposure Prophylaxis Reduces Herpes Simplex Virus Type 2 Acquisition Among Heterosexual HIV-1-Uninfected Men and Women: A Subgroup Analysis of a Randomized Trial.. Annals of internal medicine. 161(1):11-9. Abstract
E
Magaret AS, Mujugira A, Hughes JP, Lingappa J, Bukusi EA, de Bruyn G, Delany-Moretlwe S, Fife KH, Gray GE, Kapiga S et al..  2015.  Effect of Condom Use on Per-act HSV-2 Transmission Risk in HIV-1, HSV-2-discordant Couples.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. Abstract
Murnane PM, Celum C, Mugo N, Campbell JD, Donnell D, Bukusi E, Mujugira A, Tappero J, Kahle EM, Thomas KK et al..  2013.  Efficacy of preexposure prophylaxis for HIV-1 prevention among high-risk heterosexuals: subgroup analyses from a randomized trial.. AIDS (London, England). 27(13):2155-60. Abstract
Murnane PM, Brown ER, Donnell D, Coley YR, Mugo N, Mujugira A, Celum C, Baeten JM.  2015.  Estimating Efficacy in a Randomized Trial With Product Nonadherence: Application of Multiple Methods to a Trial of Preexposure Prophylaxis for HIV Prevention.. American journal of epidemiology. 182(10):848-856. Abstract
F
Mujugira A, Osoti A, Deya R, Hawes SE, Phipps AI.  2013.  Fetal head circumference, operative delivery, and fetal outcomes: a multi-ethnic population-based cohort study.. BMC pregnancy and childbirth. 13(1):106. Abstract
H
Mujugira A, Huang M-L, Selke S, Drolette L, Magaret AS, Wald A.  2015.  High Rate of β-Globin DNA Detection Validates Self-Sampling in Herpes Simplex Virus Shedding Studies.. Sexually transmitted diseases. 42(12):705-9. Abstract
Donnell D, Baeten JM, Bumpus NN, Brantley J, Bangsberg DR, Haberer JE, Mujugira A, Mugo N, Ndase P, Hendrix C et al..  2014.  HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV Prevention.. Journal of acquired immune deficiency syndromes (1999). Abstract
Kahle E, Campbell M, Lingappa J, Donnell D, Celum C, Ondondo R, Mujugira A, Fife K, Mugo N, Kapiga S et al..  2014.  HIV-1 subtype C is not associated with higher risk of heterosexual HIV-1 transmission: a multinational study among HIV-1 serodiscordant couples.. AIDS (London, England). 28(2):235-43. Abstract
I
Baeten JM, Heffron R, Kidoguchi L, Mugo NR, Katabira E, Bukusi EA, Asiimwe S, Haberer JE, Morton J, Ngure K et al..  2016.  Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda.. PLoS medicine. 13(8):e1002099. Abstract
P
Murnane PM, Heffron R, Ronald A, Bukusi EA, Donnell D, Mugo NR, Were E, Mujugira A, Kiarie J, Celum C et al..  2014.  Pre-exposure prophylaxis for HIV-1 prevention does not diminish the pregnancy prevention effectiveness of hormonal contraception.. AIDS (London, England). Abstract
Heffron R, Mugo N, Were E, Kiarie J, Bukusi EA, Mujugira A, Frenkel LM, Donnell D, Ronald A, Celum C et al..  2014.  Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception.. AIDS (London, England). 28(18):2771-6. Abstract
T
Fife KH, Mugwanya K, Thomas KK, Baeten JM, Celum C, Bukusi E, de Bruyn G, Mujugira A, Vwalika B, Wald A et al..  2015.  Transient Increase in HSV-2-Associated Genital Ulcers Following Initiation of Antiretroviral Therapy in HIV-1/HSV-2 Co-Infected Individuals.. The Journal of infectious diseases. Abstract
U
Kahle EM, Kashuba A, Baeten JM, Fife KH, Celum C, Mujugira A, Essex M, de Bruyn G, Wald A, Donnell D et al..  2014.  Unreported Antiretroviral Use by HIV-1-Infected Participants Enrolling in a Prospective Research Study.. Journal of acquired immune deficiency syndromes (1999). 65(2):e90-4.